The potential role of Staphylococcus aureus superantigens in atopic eczema

Journal of the European Academy of Dermatology and Venereology

Volumn 7, Issue SUPPL. I, 1996, Pages

  Skov, Lone ^a   Baadsgaard, Ole ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atopic dermatitis; Immune system; Staphylococcus aureus; Superantigen

Indexed keywords

SUPERANTIGEN; VIRUS PROTEIN;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; CONFERENCE PAPER; CROSS LINKING; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; LANGERHANS CELL; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION;

EID: 0030036269     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0926-9959(96)00028-1     Document Type: Conference Paper

References (17)

1. Agosti JM, Sprenger JD, Lum LG, Witherspoon RP, Fisher LD, Storb R et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. New Engl J Med 1988;319:1623-1628.
2. Saurat JH. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol Suppl (Stockh) 1985;114:125-128.
3. Taylor RS, Baadsgaard O, Hammerberg C, Cooper KD. Hyperstimulatory CD1a+CD1b+CD36 Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol 1991;147:3794-3802.
4. Lever R, Turbitt M, Sanderson A, Mackie R. Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 1987;89:4-7.
5. Grewe M, Walther S, Gyufko K, Czech W, Schöpf E, Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105:407-410.
6. + allergen specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
7. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-711.
8. Strange P, Skov L, Baadsgaard O. Interferon gamma-treated keratinocytes activate T cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules. J Invest Dermatol 1994;102:150-154.
9. Goodman RE, Nestle F, Naidu YM, Green JM, Thompson CB, Nickoloff BJ et al. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J Immunol 1994;152:5189-5198.
10. Wakita H, Tokura Y, Furukawa F, Takigawa M. Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-gamma-treated keratinocytes and keratinocyte cell line. J Invest Dermatol 1995;105:536-542.
11. Tokura Y, Yagi J, O'Malley M, Lewis JM, Takigawa M, Edelson RL et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994;102:31-38.
12. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
13. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-530.
14. Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977;113:780-782.
15. McFadden JP, Noble WC, Camp RDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993;128:631-632.
16. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189-198.
17. Hjort N, Schmidt H, Thomsen K. Fusidin acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica 1985;4:126-131.